Navigation Links
Edwards, Medtronic and Boston Scientific Lead Market Growth for Cardiac Surgery, Cardiac Rhythm Management and Interventional Cardiology Devices, Reports iData Research, Inc.
Date:10/29/2013

Vancouver, BC (PRWEB) October 29, 2013

iData Research, the leading global authority in medical device and pharmaceutical market research, has published a new report series for the U.S. Cardiology Device Markets. Cardiovascular disease is much more prevalent among patients over 55 years of age; therefore as the U.S. population ages, the incidence of cardiovascular disease will increase. In addition, rising rates of obesity will also contribute to the incidence of heart disease. As the baby boomer generation in the U.S. ages, the patient population will increase. This increase in the patient population will lead to an annual 3% to 4% increase in the number of patients requiring some type of arrhythmia treatment.

The fastest growing market among cardiac rhythm management, electrophysiology and ablation devices is diagnostic electrophysiology catheters. This market grew due to the increased use of Intracardiac Echography (ICE) and electrophysiology mapping catheters. The high average selling price of these products also bolstered market growth. Top competitors include Medtronic, St. Jude Medical and Boston Scientific.

The fastest growing areas of the cardiac surgery market will be that of transcatheter heart valve devices. These devices are used for repairing and replacing heart valves without the need for open surgery. They are expected to be widely accepted as new devices continue to be approved by the Food and Drug Administration (FDA). “The THVI market is expected to increase to represent over 15% of the total cardiac surgery market by 2019,” says Dr. Kamran Zamanian, CEO of iData. Competitors such as Edwards LifeSciences, Medtronic and Maquet together hold nearly half of the total market for cardiac surgery devices.

The U.S. market for interventional cardiology devices was valued at over $3.5 billion, with drug-eluting stents comprising the largest segment of the market, followed by coronary vascular closure devices, PTCA and cutting balloon catheters, bare-metal stents, intravascular ultrasound (IVUS) catheters, coronary introducer sheaths, interventional coronary guidewires, coronary embolic protection devices, interventional coronary catheters and balloon-inflation syringes. The report states that over the forecast period, the U.S. market for interventional cardiology is expected to exceed $4.2 billion by 2019 led by companies such as Boston Scientific, Abbott Laboratories, and St. Jude Medical. Market growth is expected to be tied to growth of the drug-eluting stent market and the expansion of the optical coherence tomography (OCT) catheter market.

In Addition to the U.S. cardiology report series, iData has research for the following countries: Japan, South Korea, China, India and Australia, Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K.

For a free report synopsis, click here.

About iData Research

iData Research is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: infusion therapy, peripheral vascular, vascular-access, drug-delivery and more.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11278478.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Potential Medtronic Infusion Pump Malfunction Claims: Resource4thePeople Attorneys Now Providing Consulations
2. Medtronic Infuse Bone Graft Lawsuit Help: Resource4thePeople Reports New Court Ruling in Favor of Plaintiffs
3. Lawsuit Against Medtronic Inc. Will Proceed, as Judge Rejects Device Maker's Preemption Arguments to Have Medtronic Infuse Case Dismissed, Parker Waichman LLP Reports
4. Arizona Judge Rejects Medtronic Inc.'s Efforts to Dismiss a Lawsuit That Alleges the Company Promoted Off-Label Use of Its Infuse Bone Graft Product, Parker Waichman LLP Reports
5. Judge Denies Medtronic’s Bid to Dismiss Lawsuit Alleging that the Off-Label Usage of its Infuse Bone Growth Product Caused Disability, Parker Waichman LLP Notes
6. Access MediQuip's Rapid Response To Medtronic Infusion Pump Recall Protects Patients
7. Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments
8. Medtronic Neurostimulator: An Implantable Device Grants Warren Man New Lease on Life
9. Medtronic's InFuse Under Intense Scrutiny and Class Action Lawsuit
10. Medtronic Infuse Bone Graft Failure Allegation Lawsuits Update: New Legal Consultations Available Over Alleged Medical Malpractice
11. Medtronic Infuse Lawsuit News: Parker Waichman LLP Alerts the Public to the June Release of Yale’s Infuse Bone Graft Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... , ... In the United States, 20 million women and 10 million men ... feel shame for having struggled with an eating disorder as well as common co-occurring ... in Life After an Eating Disorder” -- to be featured at this year’s iaedp ...
(Date:1/20/2017)... ... 2017 , ... Source Vitál Apothecary, a skin and body care company dedicated ... company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition ... in the nutritional, sports and health industries a chance to meet in private sessions ...
(Date:1/20/2017)... ... January 20, 2017 , ... International Protein, a company based out of Australia ... attended the January ECRM trade show in Hilton Head, SC. , International Protein ... to create a line of products that would elevate her fitness regime. At this ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest ... for each of his children. “The Angel” is the creation of published author, Marjorie ... York City, and impassioned writer. , When asked of her new book, Marjorie says, ...
(Date:1/20/2017)... ... , ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning ... of three in Oklahoma City, and a devoted woman of faith. , “Becoming a ... in the back of my mind for years, but actually doing it might have been ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... LONDON , January 20, 2017 Avillion ... the appointment of Mark Weinberg , MD MBA as Chief ... , USA . ... Dr Weinberg has spent more than 17 ... "top 20" pharma companies to micro-cap biotech. Over the course of ...
(Date:1/19/2017)... 2017 Report Details What can ... are going to grow at the fastest rates? This ... data, trends, opportunities and prospects. Our 190-page report ... lucrative areas in the industry and the future market ... across the all the major categories of the ophthalmic ...
(Date:1/19/2017)... Conference Call and Webcast to Follow Vanda ... will release results for the fourth quarter of 2016 on Wednesday, ... ... at 4:30 PM ET on Wednesday, February 15, 2017, during which ... results and other corporate activities. To participate in the conference call, ...
Breaking Medicine Technology: